Gilead Sciences (GILD) Assets (2009 - 2026)

Gilead Sciences (GILD) has 18 years of Assets data on file, last reported at $56.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Assets changed 0.28% year-over-year to $56.3 billion; the trailing twelve-month figure through Mar 2026 stood at $56.3 billion (changed 0.28% YoY), and the FY2025 full-year result was $59.0 billion, changed 0.05% from the prior year.
• Assets for Q1 2026 stood at $56.3 billion, down from $59.0 billion in the prior quarter.
• Across five years, Assets topped out at $63.2 billion in Q4 2022 and bottomed at $53.6 billion in Q2 2024.
• The 5-year median for Assets is $59.0 billion (2025), against an average of $59.4 billion.
• The widest annual swing landed in 2024, when Assets declined 14.05%; it then advanced 7.35% in 2025.
• A 5-year view of Assets shows it stood at $63.2 billion in 2022, then retreated by 1.66% to $62.1 billion in 2023, then declined by 5.04% to $59.0 billion in 2024, then grew by 0.05% to $59.0 billion in 2025, then fell by 4.65% to $56.3 billion in 2026.
• The last three Assets figures came in at $56.3 billion (Q1 2026), $59.0 billion (Q4 2025), and $58.5 billion (Q3 2025), per Business Quant data.

Peer Comparison